$FENCF Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FENNEC PHARMACEUTICALS INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in FENNEC PHARMACEUTICALS INC.. Get notifications about new insider transactions in FENNEC PHARMACEUTICALS INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 03 2021 | FENCF | FENNEC PHARMACEUTI ... | Goel Shubh | Chief Commercial Of ... | Option Exercise | A | 7.53 | 100,000 | 753,000 | 100,000 | |
| Jun 03 2021 | FENCF | FENNEC PHARMACEUTI ... | Andrade Robert | Chief Financial Off ... | Option Exercise | A | 7.53 | 100,000 | 753,000 | 100,000 | |
| Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Andrade Robert | Chief Financial Off ... | Payment of Exercise | F | 5.71 | 12,874 | 73,511 | 153,273 | 166.1 K to 153.3 K (-7.75 %) |
| Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Andrade Robert | Chief Financial Off ... | Payment of Exercise | F | 5.68 | 38,900 | 220,952 | 166,147 | 205 K to 166.1 K (-18.97 %) |
| Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Andrade Robert | Chief Financial Off ... | Payment of Exercise | F | 5.77 | 38,828 | 224,038 | 205,047 | 243.9 K to 205 K (-15.92 %) |
| Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Andrade Robert | Chief Financial Off ... | Payment of Exercise | F | 6.17 | 97,136 | 599,329 | 243,875 | 341 K to 243.9 K (-28.48 %) |
| Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Andrade Robert | Chief Financial Off ... | Buy | M | 1.85 | 323,961 | 599,328 | 341,011 | 17.1 K to 341 K (+1,900.06 %) |
| Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Raykov Rosty | Chief Executive Off ... | Payment of Exercise | F | 5.71 | 12,093 | 69,051 | 196,578 | 208.7 K to 196.6 K (-5.80 %) |
| Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Raykov Rosty | Chief Executive Off ... | Payment of Exercise | F | 5.68 | 38,013 | 215,914 | 208,671 | 246.7 K to 208.7 K (-15.41 %) |
| Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Raykov Rosty | Chief Executive Off ... | Payment of Exercise | F | 5.77 | 37,931 | 218,862 | 246,684 | 284.6 K to 246.7 K (-13.33 %) |
| Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Raykov Rosty | Chief Executive Off ... | Payment of Exercise | F | 6.17 | 97,136 | 599,329 | 284,615 | 381.8 K to 284.6 K (-25.44 %) |
| Aug 17 2020 | FENCF | FENNEC PHARMACEUTI ... | Raykov Rosty | Chief Executive Off ... | Buy | M | 1.85 | 323,961 | 599,328 | 381,751 | 57.8 K to 381.8 K (+560.58 %) |
| Aug 14 2020 | FENCF | FENNEC PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 6.17 | 20,000 | 123,400 | 20,000 | |
| Aug 14 2020 | FENCF | FENNEC PHARMACEUTI ... | Islam Khalid | Director | Option Exercise | A | 6.17 | 25,000 | 154,250 | 25,000 | |
| Aug 14 2020 | FENCF | FENNEC PHARMACEUTI ... | Haigh Adrian | Director | Option Exercise | A | 6.17 | 20,000 | 123,400 | 20,000 | |
| Aug 14 2020 | FENCF | FENNEC PHARMACEUTI ... | Cook Jodi A | Director | Option Exercise | A | 6.17 | 20,000 | 123,400 | 20,000 | |
| Aug 14 2020 | FENCF | FENNEC PHARMACEUTI ... | Brughera Marco Maria | Director | Option Exercise | A | 6.17 | 20,000 | 123,400 | 20,000 | |
| May 15 2020 | FENCF | FENNEC PHARMACEUTI ... | Andrade Robert | Chief Financial Off ... | Option Exercise | A | 6.93 | 125,000 | 866,250 | 125,000 | |
| May 15 2020 | FENCF | FENNEC PHARMACEUTI ... | Raykov Rosty | Chief Executive Off ... | Option Exercise | A | 6.93 | 250,000 | 1,732,500 | 250,000 | |
| May 04 2020 | FENCF | FENNEC PHARMACEUTI ... | Essetifin SPA | 10% Owner | Buy | P | 6.25 | 768,000 | 4,800,000 | 3,993,694 | 3.2 M to 4 M (+23.81 %) |
| Nov 14 2019 | FENCF | FENNEC PHARMACEUTI ... | Cook Jodi A | Director | Option Exercise | A | 5.40 | 20,000 | 108,000 | 20,000 | |
| Sep 11 2019 | FENCF | FENNEC PHARMACEUTI ... | Goel Shubh | Chief Commercial Of ... | Option Exercise | A | 4.74 | 175,000 | 829,500 | 175,000 | |
| Jun 19 2019 | FENCF | FENNEC PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 4.26 | 20,000 | 85,200 | 20,000 | |
| Jun 19 2019 | FENCF | FENNEC PHARMACEUTI ... | Haigh Adrian | Director | Option Exercise | A | 4.26 | 20,000 | 85,200 | 20,000 | |
| Jun 19 2019 | FENCF | FENNEC PHARMACEUTI ... | Islam Khalid | Director | Option Exercise | A | 4.26 | 25,000 | 106,500 | 25,000 | |
| Jun 19 2019 | FENCF | FENNEC PHARMACEUTI ... | Brughera Marco Maria | Director | Option Exercise | A | 4.26 | 20,000 | 85,200 | 20,000 | |
| Apr 08 2019 | FENCF | FENNEC PHARMACEUTI ... | Andrade Robert | Chief Financial Off ... | Option Exercise | A | 4.83 | 80,000 | 386,400 | 80,000 | |
| Apr 08 2019 | FENCF | FENNEC PHARMACEUTI ... | Raykov Rosty | Chief Executive Off ... | Option Exercise | A | 4.83 | 150,000 | 724,500 | 150,000 | |
| Aug 21 2018 | FENCF | FENNEC PHARMACEUTI ... | Raykov Rosty | Chief Executive Off ... | Buy | M | 1.44 | 17,050 | 24,552 | 40,470 | 23.4 K to 40.5 K (+72.80 %) |
| Aug 17 2018 | FENCF | FENNEC PHARMACEUTI ... | Andrade Robert | Chief Financial Off ... | Buy | M | 1.44 | 17,050 | 24,552 | 17,050 | 0 to 17.1 K |
| Jun 11 2018 | FENCF | FENNEC PHARMACEUTI ... | Islam Khalid | Director | Option Exercise | A | 10.93 | 25,000 | 273,250 | 25,000 | |
| Jun 11 2018 | FENCF | FENNEC PHARMACEUTI ... | Haigh Adrian | Director | Option Exercise | A | 10.93 | 20,000 | 218,600 | 20,000 | |
| Jun 11 2018 | FENCF | FENNEC PHARMACEUTI ... | Brughera Marco Maria | Director | Option Exercise | A | 10.93 | 20,000 | 218,600 | 20,000 | |
| Jun 11 2018 | FENCF | FENNEC PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 10.93 | 20,000 | 218,600 | 20,000 | |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 11.50 | 145,788 | 1,676,562 | 1,250,000 | 1.4 M to 1.3 M (-10.44 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 11.50 | 145,788 | 1,676,562 | 1,666,666 | 1.8 M to 1.7 M (-8.04 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 11.65 | 605 | 7,048 | 1,395,788 | 1.4 M to 1.4 M (-0.04 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 11.65 | 605 | 7,048 | 1,812,454 | 1.8 M to 1.8 M (-0.03 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 11.34 | 22,707 | 257,497 | 1,396,393 | 1.4 M to 1.4 M (-1.60 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 11.34 | 22,707 | 257,497 | 1,813,059 | 1.8 M to 1.8 M (-1.24 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 10.88 | 3,500 | 38,080 | 1,419,100 | 1.4 M to 1.4 M (-0.25 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 10.88 | 3,500 | 38,080 | 1,835,766 | 1.8 M to 1.8 M (-0.19 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 10.76 | 20,000 | 215,200 | 1,422,600 | 1.4 M to 1.4 M (-1.39 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 10.76 | 20,000 | 215,200 | 1,839,266 | 1.9 M to 1.8 M (-1.08 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 10.18 | 210,311 | 2,140,966 | 1,442,600 | 1.7 M to 1.4 M (-12.72 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 10.18 | 210,311 | 2,140,966 | 1,859,266 | 2.1 M to 1.9 M (-10.16 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.70 | 15,183 | 147,275 | 1,652,911 | 1.7 M to 1.7 M (-0.91 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.70 | 15,183 | 147,275 | 2,069,577 | 2.1 M to 2.1 M (-0.73 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.54 | 4,200 | 40,068 | 1,668,094 | 1.7 M to 1.7 M (-0.25 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.54 | 4,200 | 40,068 | 2,084,760 | 2.1 M to 2.1 M (-0.20 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.57 | 200 | 1,914 | 1,672,294 | 1.7 M to 1.7 M (-0.01 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.57 | 200 | 1,914 | 2,088,960 | 2.1 M to 2.1 M (-0.01 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.52 | 2,120 | 20,182 | 1,672,494 | 1.7 M to 1.7 M (-0.13 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.52 | 2,120 | 20,182 | 2,089,160 | 2.1 M to 2.1 M (-0.10 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.52 | 6,423 | 61,147 | 2,091,280 | 2.1 M to 2.1 M (-0.31 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.47 | 13,600 | 128,792 | 2,097,703 | 2.1 M to 2.1 M (-0.64 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.27 | 16,934 | 156,978 | 2,111,303 | 2.1 M to 2.1 M (-0.80 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.50 | 18,560 | 176,320 | 2,128,237 | 2.1 M to 2.1 M (-0.86 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.12 | 10,000 | 91,200 | 2,146,797 | 2.2 M to 2.1 M (-0.46 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.11 | 6,600 | 60,126 | 2,156,797 | 2.2 M to 2.2 M (-0.31 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.17 | 20,000 | 183,400 | 2,163,397 | 2.2 M to 2.2 M (-0.92 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.41 | 17,100 | 160,911 | 2,183,397 | 2.2 M to 2.2 M (-0.78 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 9.26 | 26,000 | 240,760 | 166,666 | 192.7 K to 166.7 K (-13.49 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 10.23 | 2,000 | 20,460 | 1,674,614 | 1.7 M to 1.7 M (+0.12 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 10.23 | 2,000 | 20,460 | 2,200,497 | 2.2 M to 2.2 M (+0.09 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 10.52 | 1,300 | 13,676 | 1,672,614 | 1.7 M to 1.7 M (+0.08 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 10.52 | 1,300 | 13,676 | 2,198,497 | 2.2 M to 2.2 M (+0.06 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 10.46 | 20,015 | 209,357 | 1,671,314 | 1.7 M to 1.7 M (+1.21 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 10.46 | 20,015 | 209,357 | 2,197,197 | 2.2 M to 2.2 M (+0.92 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 4.04 | 200 | 808 | 1,651,299 | 1.7 M to 1.7 M (+0.01 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 4.04 | 200 | 808 | 2,177,182 | 2.2 M to 2.2 M (+0.01 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 4.38 | 100 | 438 | 1,651,099 | 1.7 M to 1.7 M (+0.01 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 4.38 | 100 | 438 | 2,176,982 | 2.2 M to 2.2 M (0.00 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 3.45 | 200 | 690 | 1,650,999 | 1.7 M to 1.7 M (-0.01 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Sell | S | 3.45 | 200 | 690 | 2,176,882 | 2.2 M to 2.2 M (-0.01 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 3.45 | 600 | 2,070 | 1,651,199 | 1.7 M to 1.7 M (+0.04 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 3.45 | 600 | 2,070 | 2,177,082 | 2.2 M to 2.2 M (+0.03 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 3.39 | 600 | 2,034 | 1,650,599 | 1.6 M to 1.7 M (+0.04 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 3.39 | 600 | 2,034 | 2,176,482 | 2.2 M to 2.2 M (+0.03 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 3.03 | 2,400 | 7,272 | 1,649,999 | 1.6 M to 1.6 M (+0.15 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 3.03 | 2,400 | 7,272 | 2,175,882 | 2.2 M to 2.2 M (+0.11 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.97 | 2,000 | 5,940 | 1,647,599 | 1.6 M to 1.6 M (+0.12 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.97 | 2,000 | 5,940 | 2,173,482 | 2.2 M to 2.2 M (+0.09 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.80 | 700 | 1,960 | 1,645,599 | 1.6 M to 1.6 M (+0.04 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.80 | 700 | 1,960 | 2,171,482 | 2.2 M to 2.2 M (+0.03 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.68 | 2,000 | 5,360 | 1,644,899 | 1.6 M to 1.6 M (+0.12 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.68 | 2,000 | 5,360 | 2,170,782 | 2.2 M to 2.2 M (+0.09 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.66 | 8,000 | 21,280 | 1,642,899 | 1.6 M to 1.6 M (+0.49 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.66 | 8,000 | 21,280 | 2,168,782 | 2.2 M to 2.2 M (+0.37 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.13 | 200 | 426 | 1,634,899 | 1.6 M to 1.6 M (+0.01 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.13 | 200 | 426 | 2,160,782 | 2.2 M to 2.2 M (+0.01 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.34 | 100 | 234 | 1,634,699 | 1.6 M to 1.6 M (+0.01 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.34 | 100 | 234 | 2,160,582 | 2.2 M to 2.2 M (0.00 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.97 | 2,000 | 3,940 | 1,634,599 | 1.6 M to 1.6 M (+0.12 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.97 | 2,000 | 3,940 | 2,160,482 | 2.2 M to 2.2 M (+0.09 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.21 | 2,000 | 4,420 | 1,632,599 | 1.6 M to 1.6 M (+0.12 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.21 | 2,000 | 4,420 | 2,158,482 | 2.2 M to 2.2 M (+0.09 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.88 | 9,500 | 17,860 | 1,630,599 | 1.6 M to 1.6 M (+0.59 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.88 | 9,500 | 17,860 | 2,156,482 | 2.1 M to 2.2 M (+0.44 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.00 | 5,000 | 10,000 | 1,621,099 | 1.6 M to 1.6 M (+0.31 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.00 | 5,000 | 10,000 | 2,146,982 | 2.1 M to 2.1 M (+0.23 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.87 | 2,000 | 3,740 | 1,616,099 | 1.6 M to 1.6 M (+0.12 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.87 | 2,000 | 3,740 | 2,141,982 | 2.1 M to 2.1 M (+0.09 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.02 | 1,000 | 2,020 | 1,614,099 | 1.6 M to 1.6 M (+0.06 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.02 | 1,000 | 2,020 | 2,139,982 | 2.1 M to 2.1 M (+0.05 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.04 | 1,000 | 2,040 | 1,613,099 | 1.6 M to 1.6 M (+0.06 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.04 | 1,000 | 2,040 | 2,138,982 | 2.1 M to 2.1 M (+0.05 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.09 | 5,000 | 10,450 | 1,612,099 | 1.6 M to 1.6 M (+0.31 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.09 | 5,000 | 10,450 | 2,137,982 | 2.1 M to 2.1 M (+0.23 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.06 | 7,000 | 14,420 | 1,607,099 | 1.6 M to 1.6 M (+0.44 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.06 | 7,000 | 14,420 | 2,132,982 | 2.1 M to 2.1 M (+0.33 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.11 | 100 | 211 | 1,600,099 | 1.6 M to 1.6 M (+0.01 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.11 | 100 | 211 | 2,125,982 | 2.1 M to 2.1 M (0.00 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.01 | 11,100 | 22,311 | 1,599,999 | 1.6 M to 1.6 M (+0.70 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.01 | 11,100 | 22,311 | 2,125,882 | 2.1 M to 2.1 M (+0.52 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.12 | 1,600 | 3,392 | 1,588,899 | 1.6 M to 1.6 M (+0.10 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.12 | 1,600 | 3,392 | 2,114,782 | 2.1 M to 2.1 M (+0.08 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.14 | 400 | 856 | 1,587,299 | 1.6 M to 1.6 M (+0.03 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.14 | 400 | 856 | 2,113,182 | 2.1 M to 2.1 M (+0.02 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.32 | 100 | 232 | 1,586,899 | 1.6 M to 1.6 M (+0.01 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.32 | 100 | 232 | 2,112,782 | 2.1 M to 2.1 M (0.00 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.30 | 7,000 | 16,100 | 1,586,799 | 1.6 M to 1.6 M (+0.44 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.30 | 7,000 | 16,100 | 2,112,682 | 2.1 M to 2.1 M (+0.33 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.23 | 1,000 | 2,230 | 1,579,799 | 1.6 M to 1.6 M (+0.06 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.23 | 1,000 | 2,230 | 2,105,682 | 2.1 M to 2.1 M (+0.05 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.59 | 15,700 | 40,663 | 1,578,799 | 1.6 M to 1.6 M (+1.00 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.59 | 15,700 | 40,663 | 2,104,682 | 2.1 M to 2.1 M (+0.75 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.36 | 2,425 | 5,723 | 1,563,099 | 1.6 M to 1.6 M (+0.16 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.36 | 2,425 | 5,723 | 2,088,982 | 2.1 M to 2.1 M (+0.12 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.45 | 300 | 735 | 1,560,674 | 1.6 M to 1.6 M (+0.02 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.45 | 300 | 735 | 2,086,557 | 2.1 M to 2.1 M (+0.01 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.45 | 5,000 | 12,250 | 1,560,374 | 1.6 M to 1.6 M (+0.32 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.45 | 5,000 | 12,250 | 2,086,257 | 2.1 M to 2.1 M (+0.24 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.02 | 11,000 | 22,220 | 1,555,374 | 1.5 M to 1.6 M (+0.71 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.02 | 11,000 | 22,220 | 2,081,257 | 2.1 M to 2.1 M (+0.53 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.92 | 20,000 | 38,400 | 1,544,374 | 1.5 M to 1.5 M (+1.31 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.92 | 20,000 | 38,400 | 2,070,257 | 2.1 M to 2.1 M (+0.98 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.67 | 10,100 | 16,867 | 1,524,374 | 1.5 M to 1.5 M (+0.67 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.67 | 10,100 | 16,867 | 2,050,257 | 2 M to 2.1 M (+0.50 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.63 | 11,000 | 17,930 | 1,514,274 | 1.5 M to 1.5 M (+0.73 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.63 | 11,000 | 17,930 | 2,040,157 | 2 M to 2 M (+0.54 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.67 | 3,000 | 5,010 | 1,503,274 | 1.5 M to 1.5 M (+0.20 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.67 | 3,000 | 5,010 | 2,029,157 | 2 M to 2 M (+0.15 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.10 | 4,000 | 8,400 | 1,500,274 | 1.5 M to 1.5 M (+0.27 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 2.10 | 4,000 | 8,400 | 2,026,157 | 2 M to 2 M (+0.20 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.98 | 4,800 | 9,504 | 1,496,274 | 1.5 M to 1.5 M (+0.32 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT PR, LLC | 10% Owner | Buy | P | 1.98 | 4,800 | 9,504 | 2,022,157 | 2 M to 2 M (+0.24 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT CO LLC | 10% Owner | Buy | P | 1.84 | 4,300 | 7,912 | 1,491,474 | 1.5 M to 1.5 M (+0.29 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT CO LLC | 10% Owner | Buy | P | 1.84 | 4,300 | 7,912 | 2,017,357 | 2 M to 2 M (+0.21 %) |
| Mar 29 2018 | FENCF | FENNEC PHARMACEUTI ... | MANCHESTER MANAGEMENT CO LLC | 10% Owner | Buy | P | 1.77 | 9,000 | 15,930 | 1,487,174 | 1.5 M to 1.5 M (+0.61 %) |